Modern Chinese Medicine Group Co Ltd (1643.HK)

Healthcare | Drug Manufacturers General
Income Statement (Quarterly) 2026-04-08 2025-06-30 2025-03-31 2024-12-31
Revenue 64,757,998 64,757,998 32,378,999 68,722,000
Cost of Revenue 48,568,000 48,568,000 24,284,000 51,975,000
Gross Profit 16,190,000 16,190,000 8,095,000 16,747,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 14,163,000 14,163,000 7,081,500 6,875,000
Operating Expenses 14,163,000 14,163,000 7,081,500 7,625,000
Operating Income 2,026,998 2,026,998 1,013,499 9,122,000
Interest Expense 0 0 0 0
Income Before Tax 3,430,000 3,430,000 1,715,000 9,573,500
Income Tax Expense 977,000 977,000 488,500 1,312,500
Net Income 2,453,000 2,453,000 1,226,500 8,261,000
Per Share
EPS 0.00 0.00 0.00 0.01
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 214,068,000 344,075,000 399,656,000
Cost of Revenue 158,871,000 239,900,000 228,870,000
Gross Profit 55,197,000 104,175,000 170,786,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 31,368,000 35,808,000 41,691,000
Operating Expenses 32,868,000 37,308,000 41,629,000
Operating Income 22,329,000 66,867,000 124,338,000
Interest Expense 1,000 5,000 14,000
Income Before Tax 14,819,000 68,306,000 124,324,000
Income Tax Expense 5,149,000 19,511,000 36,495,000
Net Income 9,670,000 48,795,000 87,829,000
Per Share
EPS 0.02 0.08 0.15
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 229,668,000 286,266,000 282,256,000
Short Term Investments 0 0 0
Net Receivables 88,483,000 103,085,000 0
Inventory 30,549,000 46,466,000 41,509,000
Total Current Assets 352,506,000 436,513,000 402,490,000
Property Plant Equipment 186,868,000 87,711,000 90,041,000
Goodwill and Intangibles 97,000 195,000 292,000
Total Assets 540,308,000 528,532,000 501,534,000
Liabilities
Account Payables 32,577,000 31,278,000 39,261,000
Short Term Debt 66,000 72,000 393,000
Total Current Liabilities 48,960,000 48,888,000 73,354,000
Long Term Debt 69,000 0 0
Total Liabilities 56,083,000 55,643,000 78,600,000
Shareholders Equity
Retained Earnings 331,099,000 321,429,000 257,521,000
Total Shareholders Equity 484,225,000 472,889,000 422,934,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 229,668,000 286,266,000 282,256,000
Short Term Investments 0 0 0
Net Receivables 88,483,000 103,085,000 0
Inventory 30,549,000 46,466,000 41,509,000
Total Current Assets 352,506,000 436,513,000 402,490,000
Property Plant Equipment 186,868,000 87,711,000 90,041,000
Goodwill and Intangibles 97,000 195,000 292,000
Total Assets 540,308,000 528,532,000 501,534,000
Liabilities
Account Payables 32,577,000 31,278,000 39,261,000
Short Term Debt 66,000 72,000 393,000
Total Current Liabilities 48,960,000 48,888,000 73,354,000
Long Term Debt 69,000 0 0
Total Liabilities 56,083,000 55,643,000 78,600,000
Shareholders Equity
Retained Earnings 331,099,000 321,429,000 257,521,000
Total Shareholders Equity 484,225,000 472,889,000 422,934,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 14,819,000 48,795,000 124,324,000
Depreciation & Amortization 9,274,000 6,440,000 5,691,000
Stock Based Compensation 0 0 0
Change in Working Capital 28,063,000 -44,921,000 24,055,000
Operating Cash Flow 58,982,000 8,476,000 125,786,000
Investing Activities
Capital Expenditure -114,303,000 -5,098,000 -11,723,000
Investments -114,303,000 -5,098,000 -11,723,000
Investing Cash Flow -115,487,000 -4,192,000 -11,048,000
Financing Activities
Debt Repayment 0 -321,000 0
Common Stock Issued/Repurchased 0 0 0
Dividends Paid 0 0 -8,322,000
Financing Cash Flow -144,000 -326,000 -8,726,000
Summary
Free Cash Flow -55,321,000 3,378,000 114,063,000
Net Change in Cash -56,598,000 4,010,000 106,165,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 14,819,000 48,795,000 124,324,000
Depreciation & Amortization 9,274,000 6,440,000 5,691,000
Stock Based Compensation 0 0 0
Change in Working Capital 28,063,000 -44,921,000 24,055,000
Operating Cash Flow 58,982,000 8,476,000 125,786,000
Investing Activities
Capital Expenditure -114,303,000 -5,098,000 -11,723,000
Investments -114,303,000 -5,098,000 -11,723,000
Investing Cash Flow -115,487,000 -4,192,000 -11,048,000
Financing Activities
Debt Repayment 0 -321,000 0
Common Stock Issued/Repurchased 0 0 0
Dividends Paid 0 0 -8,322,000
Financing Cash Flow -144,000 -326,000 -8,726,000
Summary
Free Cash Flow -55,321,000 3,378,000 114,063,000
Net Change in Cash -56,598,000 4,010,000 106,165,000